- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Transcription Initiation.
Displaying page 1 of 1.
EudraCT Number: 2013-004747-23 | Sponsor Protocol Number: BPC01-001 | Start Date*: 2014-01-17 | |||||||||||
Sponsor Name:Bionor Pharma ASA | |||||||||||||
Full Title: An Open Phase I/IIa Study to Evaluate the Safety and Effect of Therapeutic HIV-1 Immunization using Vacc-4x + rhuGM-CSF, and HIV-1 Reactivation using Romidepsin, on the Viral Reservoir in Virologic... | |||||||||||||
Medical condition: HIV-infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005001-78 | Sponsor Protocol Number: KLI148-B00 | Start Date*: 2012-01-26 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie | ||
Full Title: Neural Correlates of SSRI Drug Response: Impact of Stress System Genes | ||
Medical condition: Major Depressive Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001467-82 | Sponsor Protocol Number: P020.051 | Start Date*: 2020-10-23 | ||||||||||||||||
Sponsor Name:Leiden University Medical Center | ||||||||||||||||||
Full Title: An Open-Label Study Evaluating Anti-Viral Effects of Voclosporin in SARS-CoV-2 Positive Kidney Transplant Recipients – the VOCOVID Study (COVID-19) | ||||||||||||||||||
Medical condition: SARS-CoV-2 infection in Kidney Transplant Recipients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000455-39 | Sponsor Protocol Number: C21-109-09 | Start Date*: 2021-04-09 | |||||||||||
Sponsor Name:Pharma Holdings AS | |||||||||||||
Full Title: A double-blind, placebo-controlled, interventional parallel group study to evaluate the antiviral effect of a single nasal application of LTX-109 3% gel, in comparison to placebo gel, in subjects w... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005980-30 | Sponsor Protocol Number: 53718678RSV2008 | Start Date*: 2021-11-26 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rilematovir (JNJ-53718678) in Adult Outpatients with Respiratory Syncytial Virus (RSV) Infection... | |||||||||||||
Medical condition: Respiratory Syncytial Virus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) PL (Completed) HU (Ongoing) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003642-93 | Sponsor Protocol Number: 53718678RSV2002 | Start Date*: 2018-12-05 | ||||||||||||||||
Sponsor Name:Janssen Sciences Ireland UC | ||||||||||||||||||
Full Title: A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses o... | ||||||||||||||||||
Medical condition: Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) ES (Prematurely Ended) HU (Completed) SE (Completed) FR (Completed) DE (Prematurely Ended) PL (Completed) BG (Completed) Outside EU/EEA IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002257-37 | Sponsor Protocol Number: UC-0105/1611 | Start Date*: 2017-02-10 |
Sponsor Name:UNICANCER | ||
Full Title: Secured access to nivolumab for adult patients with selected rare cancer types | ||
Medical condition: Unresectable locally advanced or metastatic, non-clear cell renal cell carcinoma, rare head and neck cancer, rare skin cancer, MSI-nonCRC or penile cancer, which is resistant or refractory to stand... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003780-21 | Sponsor Protocol Number: RP1907 | Start Date*: 2020-03-31 | |||||||||||
Sponsor Name:Alimentiv Inc. | |||||||||||||
Full Title: Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis (PROPHETIC Study) | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004358-32 | Sponsor Protocol Number: IJB–TNBC–1–RHEA | Start Date*: 2015-05-07 | |||||||||||
Sponsor Name:Institut Jules Bordet | |||||||||||||
Full Title: Biomarker Research Study for PF-03084014 in cHEmoresistant triple negative breast cAncer - “RHEA” study | |||||||||||||
Medical condition: patients with chemoresistant, triple-negative breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002841-39 | Sponsor Protocol Number: GINECO-OV-222 | Start Date*: 2013-10-07 | |||||||||||
Sponsor Name:ARCAGY GINECO | |||||||||||||
Full Title: A randomized, open label, phase II trial of bevacizumab plus weekly paclitaxel followed by bevacizumab monotherapy maintenance versus weekly paclitaxel followed by observation in patients with rela... | |||||||||||||
Medical condition: Patients with an histologically confirmed diagnosis of ovarian sex-cord stromal tumor in relapse after a platinum-based chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003998-22 | Sponsor Protocol Number: CV-NCOV-004 | Start Date*: 2020-12-16 | |||||||||||
Sponsor Name:CureVac AG | |||||||||||||
Full Title: COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 1... | |||||||||||||
Medical condition: Vaccination for prophylaxis of COVID-19 (healthy adults) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) NL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005488-18 | Sponsor Protocol Number: 8628-006 | Start Date*: 2016-05-12 | |||||||||||||||||||||
Sponsor Name:Oncoethix GmbH, a wholly owned subsidiary of Merck Sharp & Dohme Corp. | |||||||||||||||||||||||
Full Title: A Phase IB Dose Exploration Trial with MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects with Selected Advanced Solid Tumors | |||||||||||||||||||||||
Medical condition: NUT Midline Carcinoma Non-Small Cell Lung Cancer Triple-Negative Breast Cancer Castration-Resistant Prostate Cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) BE (Completed) FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.